CapsoVision Inc. (CV:NASDAQ) closed at $6.99 on October 23, 2026, up 2.79% on the day. The stock trades 54.5% below its 52-week high of $15.37 and 55.3% above its 52-week low of $4.50. Over the past year, it gained 42.7%. CapsoVision Inc. is part of the Health Care sector.
In 252 trading sessions since October 23, 2025, CV closed higher on 122 days (48%). Its best day was December 10, 2025 (+32.73%) and its worst was January 5, 2026 (-17.09%). The stock moved 10% or more in a single session 24 times.
CapsoVision is a commercial-stage medical technology company that develops advanced imaging and artificial intelligence technologies that are deployed in our capsule endoscopy solutions to identify abnormalities of the gastrointestinal tract for diagnostic and screening purposes. We developed our first capsule endoscope system, currently comprising the CapsoCam Plus single-use capsule and the CapsoCloud and CapsoView software, to panoramically visualize the small-bowel mucosa to investigate abnormalities such as obscure GI bleeding and Crohn's disease. The CapsoCam Plus is classified as a Class II device and has received FDA marketing authorization through the 510(k) clearance process.
Find more stocks like CV with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.